Bispecific antibodies (BsAbs) are used to treat many conditions, and there is great hope that new antibody therapies will help in the treatment of many other diseases, including cancers, autoimmune disorders, and infectious diseases in the future. Find out more about BsAbs – what they are and how their activity can be quantified using cell-based reporter-gene assays.
The use of therapeutic monoclonal antibodies (mAbs) has revolutionized the treatment of many disorders over the last decades. Therapeutic mAbs represent the largest class of biopharmaceuticals and are increasingly used to treat common conditions such as cancer and autoimmune diseases.